Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype
Surgical Oncology Clinics of North America · 2023
DOI: 10.1016/j.soc.2022.10.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Surgical Oncology Clinics of North America, 2023. Verfasst von Bhavishya Ramamoorthy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Oncology Program, Endocrine Surgery Section, National Cancer Institute, NIH, 10 Center Drive, Building 10 - Room 45952, Bethesda, MD 20892, …. Hauptthemen laut MEDLINE: Multiple Endocrine Neoplasia Type 1, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors, Pancreatic Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Multiple endocrine neoplasia type 1 syndrome (MEN1) is a disease caused by mutations in the MEN1 tumor suppressor gene leading to hyperparathyroidism, pituitary adenomas, and entero-pancreatic neuroendocrine tumors. Pancreatic neuroendocrine tumors (PNETs) are a major cause of mortality in patients with MEN1. Identification of consistent genotype-phenotype correlations has remained elusive, but MEN1 mutations in exons 2, 9, and 10 may be associated with metastatic PNETs; patients with these mutations may benefit from more intensive surveillance and aggressive treatment. In addition, epigenetic differences between MEN1-associated PNETs and sporadic PNETs are beginning to emerge, but further investigation is required to establish clear phenotypic associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Surgical Oncology Program, Endocrine Surgery Section, National Cancer Institute, NIH, 10 Center Drive, Building 10 - Room 45952, Bethesda, MD 20892, USA.
- Surgical Oncology Program, Endocrine Surgery Section, National Cancer Institute, NIH, 10 Center Drive, Building 10 - Room 45952, Bethesda, MD 20892, USA. Electronic address: naris.nilubol@nih.gov.
Förderung
- Intramural NIH HHS
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Ramamoorthy, B., & Nilubol, N. (2023). Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype. Surgical Oncology Clinics of North America. https://doi.org/10.1016/j.soc.2022.10.008
Vancouver
Ramamoorthy B, Nilubol N. Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype. Surgical Oncology Clinics of North America. 2023. doi:10.1016/j.soc.2022.10.008
BibTeX
@article{Ramamoorthy2023,
author = {Ramamoorthy, Bhavishya and Nilubol, Naris},
title = {Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype},
journal = {Surgical Oncology Clinics of North America},
year = {2023},
doi = {10.1016/j.soc.2022.10.008}
}
EUVIMED